Propanc Biopharma, Inc.
PPCB· Nasdaq
PPCBPropanc Biopharma, Inc.
Filed May 8, 2017 · 10-Q · 38 days after period end · 0001493152-17-004870
| Metric | Q3 2017 | Q3 2016 | Q3 2015 | Q3 2014 |
|---|---|---|---|---|
| Net Income | -$1.37M | -$2.15M | -$454.25K | -$66.87K |
| EPS Diluted | -$0.38 | -$1.05 | $0.00 | $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Propanc Biopharma, Inc. · CIK 1517681 · Engraved from SEC EDGAR
ended Mar 31, 2017 · filed May 8, 2017 · 38 d after period end
